CD4 and acute myeloid leukemia: In addition, increased numbers and function of regulatory T cells in both the peripheral blood and bone marrow of AML patients have been reported, with bone marrow-resident regulatory T cells exhibiting more immunosuppressive effects on CD4+ effector T cell proliferation[15].